Cadila Pharms Ltd Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for CADILA PHARMS LTD, and what generic and branded alternatives to CADILA PHARMS LTD drugs are available?
CADILA PHARMS LTD has twenty-six approved drugs.
There is one tentative approval on CADILA PHARMS LTD drugs.
Summary for Cadila Pharms Ltd
| US Patents: | 0 |
| Tradenames: | 24 |
| Ingredients: | 24 |
| NDAs: | 26 |
Drugs and US Patents for Cadila Pharms Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cadila Pharms Ltd | HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride | TABLET;ORAL | 203845-003 | Sep 18, 2014 | AA | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| Cadila Pharms Ltd | GEMFIBROZIL | gemfibrozil | TABLET;ORAL | 203266-001 | Jun 17, 2016 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| Cadila Pharms Ltd | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 211323-002 | Aug 29, 2019 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
